MetaCap

NewAmsterdam Pharma N.V. (NAMS) News

NASDAQ: NAMSHealth CareBiotechnology: Pharmaceutical PreparationsUSD

18.41-1.10 (-5.64%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

NAMS news summary

We found 3 recent headlines mentioning NewAmsterdam Pharma N.V. (NAMS): 0 in the past week and 3 in the past 30 days, most often from GlobeNewswire, Nasdaq. NAMS is making an outsized move today, down 5.64% at $18.41, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)", was published by GlobeNewswire on Nov 6, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest NewAmsterdam Pharma N.V. headlines

Compare NAMS